Christmas rush for pharma IPOs

摘要

Indian pharmaceutical and healthcare companies are lining up to raise a combined US$375m from IPOs before the year ends, taking advantage of growing demand for the sector. Alkem Laboratories leads the pack with its Rsl3bn (US$202m) IPO of 12.8m secondary shares in the Rs1,020-1,050 range. Anchor books open on December 7 and the rest of the offer will run from December 8-10. The Rs6.2bn-Rs6.3bn IPO of dr lal Pathlabs, the first IPO from an Indian diagnostic centre, is running neck-and-neck with that of Alkem. About 11.6m secondary shares are being sold in the IPO at a price range of Rs540-Rs550.